Search - tctmd.com

Displaying 341 - 360 of 1073

Sort: Relevancy | Date

Antithrombotic therapy does not provide a benefit for clinically stable but symptomatic outpatients with COVID-19, published results of the ACTIV-4b trial affirm. Neither aspirin nor apixaban (Eliquis; Bristol Myers Squibb) at prophylactic or therapeutic doses reduced what were already very low rates of major adverse cardiopulmonary outcomes versus placebo, and both modestly increased bleeding, researchers led by Jean Connors, MD (Brigham and Women’s Hospital, Boston, MA), report in a paper published online

News Daily News

ACTIV-4b: No Antithrombotic Therapy Needed for COVID-19 Outpatients

October 13, 2021

COVID-19: TCTMD’s Dispatch for October Week 2

News Daily News

COVID-19: TCTMD’s Dispatch for October Week 2

October 11, 2021

Diabetes Progression in Statin-Treated Patients: VA Data

News Daily News

Diabetes Progression in Statin-Treated Patients: VA Data

Michael O'Riordan

October 06, 2021

SWEDEHEART Data Reassure on 10-Year Survival for TAVI Patients With Pacemakers

News Daily News

SWEDEHEART Data Reassure on 10-Year Survival for TAVI Patients With Pacemakers

October 05, 2021

Device-Detected AF Directly Linked to Ischemic Strokes

News Daily News

Device-Detected AF Directly Linked to Ischemic Strokes

October 04, 2021

COVID-19: TCTMD’s Dispatch for October Week 1

News Daily News

COVID-19: TCTMD’s Dispatch for October Week 1

October 04, 2021

COVID-19: TCTMD’s Dispatch for September Week 5

News Daily News

COVID-19: TCTMD’s Dispatch for September Week 5

September 27, 2021

COVID-19: TCTMD’s Daily Dispatch for September Week 4

News Daily News

COVID-19: TCTMD’s Daily Dispatch for September Week 4

September 20, 2021

COVID-19: TCTMD’s Daily Dispatch for September Week 3

News Daily News

COVID-19: TCTMD’s Daily Dispatch for September Week 3

September 13, 2021

COVID-19: TCTMD’s Daily Dispatch for September Week 2

News Daily News

COVID-19: TCTMD’s Daily Dispatch for September Week 2

September 08, 2021

COVID-19: TCTMD’s Daily Dispatch for September Week 1

News Daily News

COVID-19: TCTMD’s Daily Dispatch for September Week 1

August 30, 2021

COVID-19: TCTMD’s Daily Dispatch for August Week 4

News Daily News

COVID-19: TCTMD’s Daily Dispatch for August Week 4

August 22, 2021

Uptick in ‘Implausible’ Cancers Reported After ARB Recalls

News Daily News

Uptick in ‘Implausible’ Cancers Reported After ARB Recalls

August 20, 2021

FDA Green-lights Empagliflozin for HF With Reduced Ejection Fraction

News Daily News

FDA Green-lights Empagliflozin for HF With Reduced Ejection Fraction

Michael O'Riordan

August 19, 2021

Endpoint Reporting in Medical Journals Needs to Be Revamped: Review

News Daily News

Endpoint Reporting in Medical Journals Needs to Be Revamped: Review

Michael O'Riordan

August 17, 2021

COVID-19: TCTMD’s Daily Dispatch for August Week 3

News Daily News

COVID-19: TCTMD’s Daily Dispatch for August Week 3

August 15, 2021

One in Six HF Patients Delay or Forego Care, Inflating Costs

News Daily News

One in Six HF Patients Delay or Forego Care, Inflating Costs

August 12, 2021

Therapeutic-Dose Heparin in COVID-19: Who Benefits, Who Doesn’t

News Daily News

Therapeutic-Dose Heparin in COVID-19: Who Benefits, Who Doesn’t

August 04, 2021

COVID-19: TCTMD’s Daily Dispatch for August Week 1

News Daily News

COVID-19: TCTMD’s Daily Dispatch for August Week 1

August 01, 2021

MitraClip Viable in Shock Patients With Significant MR: Observational Study

News Daily News

MitraClip Viable in Shock Patients With Significant MR: Observational Study

Michael O'Riordan

July 29, 2021

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.